Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Compound heterozygotes for filaggrin gene mutations do not always show severe atopic dermatitis.
Sekiya A, Kono M, Tsujiuchi H, Kobayashi T, Nomura T, Kitakawa M, Suzuki N, Yamanaka K, Sueki H, McLean WH, Shimizu H, Akiyama M. Sekiya A, et al. Among authors: tsujiuchi h. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):158-162. doi: 10.1111/jdv.13871. Epub 2016 Aug 13. J Eur Acad Dermatol Venereol. 2017. PMID: 27519469
IgE-independent pathophysiology of severe atopic dermatitis demonstrated in an IgE-deficient patient.
Ogawa Y, Kono M, Tsujikawa M, Tsujiuchi H, Akiyama M. Ogawa Y, et al. Among authors: tsujiuchi h. J Dermatol Sci. 2016 May;82(2):139-41. doi: 10.1016/j.jdermsci.2016.01.008. Epub 2016 Jan 21. J Dermatol Sci. 2016. PMID: 26846942 No abstract available.
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations.
Kono M, Nomura T, Ohguchi Y, Mizuno O, Suzuki S, Tsujiuchi H, Hamajima N, McLean WH, Shimizu H, Akiyama M. Kono M, et al. Among authors: tsujiuchi h. Allergy. 2014 Apr;69(4):537-40. doi: 10.1111/all.12369. Epub 2014 Jan 28. Allergy. 2014. PMID: 24467288
Tryptamine-based human beta3-adrenergic receptor agonists. Part 3: improved oral bioavailability via modification of the sulfonamide moiety.
Sawa M, Mizuno K, Harada H, Tateishi H, Arai Y, Suzuki S, Oue M, Tsujiuchi H, Furutani Y, Kato S. Sawa M, et al. Among authors: tsujiuchi h. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1061-4. doi: 10.1016/j.bmcl.2004.12.033. Bioorg Med Chem Lett. 2005. PMID: 15686912
Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human beta3-adrenergic receptor agonists with high cell permeability.
Mizuno K, Sawa M, Harada H, Taoka I, Yamashita H, Oue M, Tsujiuchi H, Arai Y, Suzuki S, Furutani Y, Kato S. Mizuno K, et al. Among authors: tsujiuchi h. Bioorg Med Chem. 2005 Feb 1;13(3):855-68. doi: 10.1016/j.bmc.2004.10.032. Bioorg Med Chem. 2005. PMID: 15653351
Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.
Sawa M, Tateishi H, Mizuno K, Harada H, Oue M, Tsujiuchi H, Furutani Y, Kato S. Sawa M, et al. Among authors: tsujiuchi h. Bioorg Med Chem Lett. 2004 Dec 20;14(24):5963-6. doi: 10.1016/j.bmcl.2004.09.054. Bioorg Med Chem Lett. 2004. PMID: 15546708
Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
Mizuno K, Sawa M, Harada H, Tateishi H, Oue M, Tsujiuchi H, Furutani Y, Kato S. Mizuno K, et al. Among authors: tsujiuchi h. Bioorg Med Chem Lett. 2004 Dec 20;14(24):5959-62. doi: 10.1016/j.bmcl.2004.10.035. Bioorg Med Chem Lett. 2004. PMID: 15546707
Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene.
Tambe Y, Tsujiuchi H, Honda G, Ikeshiro Y, Tanaka S. Tambe Y, et al. Among authors: tsujiuchi h. Planta Med. 1996 Oct;62(5):469-70. doi: 10.1055/s-2006-957942. Planta Med. 1996. PMID: 9005452
Feedback